Tag Archives: s. 101

Legal Wiggle Room in the Joint AIPLA-IPO Proposal on Patentability?

Posted on December 11, 2018 by Warren Woessner

I recently took another look at the Joint AIPLA-IPO Proposal on Patent Eligibility that was prompted by the scheduling of a discussion meeting by the Minnesota Intellectual Property Law Association. I confess that I did not participate in either the … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | Leave a comment

Life Science Patenting to Iancu – “We need help too!”

Posted on December 2, 2018 by Warren Woessner

In his remarks presented at the recent 10th Annual Patent Law & Policy Conference at Georgetown University Law School, USPTO Director Andrei Iancu outlined the analytical framework for the new, eagerly awaited, PTO Guidance on patent eligible subject matter. Although … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | Leave a comment

Director Iancu’s IPO Address and Judge Rich

Posted on September 27, 2018 by Warren Woessner

Although Director Iancu’s address primarily aims at the difficulty of determining when a claim is directed to an abstract idea, his precursor guiding light is clearly the late Judge Giles Rich. Notably, Iancu quotes from Judge Rich. These quotes are … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | Leave a comment

Ex parte Ho – Burden Shifting in s.101 Rejections

Posted on September 12, 2018 by Warren Woessner

In Judge Plager’s concurrence-in-part in Interval Licensing v. AOL, Inc., he describes the “small puzzle” present in the Mayo/Alice analysis of a claim identified as directed to an abstract idea: “[I]f a court, after reviewing challenged claims in light of … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , | Leave a comment